140.08
+3.31(+2.42%)
Currency In USD
| Previous Close | 136.77 |
| Open | 136.77 |
| Day High | 142.56 |
| Day Low | 136.32 |
| 52-Week High | 157.13 |
| 52-Week Low | 55.92 |
| Volume | 383,647 |
| Average Volume | 513,432 |
| Market Cap | 4.47B |
| PE | -44.75 |
| EPS | -3.13 |
| Moving Average 50 Days | 142.13 |
| Moving Average 200 Days | 108.69 |
| Change | 3.31 |
If you invested $1000 in iRhythm Technologies, Inc. (IRTC) since IPO date, it would be worth $5,377.35 as of July 31, 2025 at a share price of $140.08. Whereas If you bought $1000 worth of iRhythm Technologies, Inc. (IRTC) shares 5 years ago, it would be worth $1,125.32 as of July 31, 2025 at a share price of $140.08.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
GlobeNewswire Inc.
Jul 17, 2025 8:30 PM GMT
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release f
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
GlobeNewswire Inc.
Jul 07, 2025 12:30 PM GMT
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
GlobeNewswire Inc.
Jun 23, 2025 12:30 PM GMT
Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major cardiovascular events (MACE)SAN FRANCISCO, June 23, 202